Frank Lauster

Learn More
The postdialytic plasma level of cGMP, a marker for the release of atrial natriuretic peptide (ANP) in humans, is closely related to hypervolemia in chronic hemodialysis patients. In order to test the practicability of routine postdialysis cGMP determination for the detection of fluid overload, ANP and cGMP levels in the total hemodialysis population of 81(More)
BACKGROUND Stage I of a preplanned 2-stage study has provided good evidence for improved glycemic control with a disease-specific enteral formula low in carbohydrates and high in monounsaturated fatty acids (MUFAs), fish oil, chromium, and antioxidants in insulin-treated type 2 diabetes. The study was continued with stage II to give confirmatory proof of(More)
OBJECTIVES To investigate the effects of long-term treatment with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids (MUFAs), in comparison with a standard formula, on glycaemic control in tube-fed type II diabetic patients. DESIGN Randomised, double-blind, controlled, multi-centre trial. SETTING Early rehabilitation(More)
We investigated, whether plasma cyclic guanosine 3':5'-monophosphate (cGMP) may be suited as a marker of hyperhydration in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). In 81 HD patients the levels of atrial natriuretic peptide (ANP) and cGMP were markedly elevated before HD (ANP: 165 +/- 11.1 pg/ml; cGMP 43.5 +/- 2.2 pmol/ml).(More)
We investigated whether cGMP might be a suitable marker of ideal weight in chronic haemodialysis patients. In 20 patients on chronic haemodialysis (10 males, 10 females, mean age 55.5 +/- 7.4 years; mean interdialytic weight gain 2.4 +/- 1.1 kg) we determined plasma ANP and cGMP values before and after several haemodialysis treatments. ANP and cGMP before(More)
Thirty-seven patients with volume-retaining disorders (liver cirrhosis with ascites,n=8; heart failure NYHA III–IV,n=12; endstage renal failure,n=17) and twelve healthy age-matched controls were given a small dose (33 μg) of hANF (human atrial natriuretic factor). We tested the resulting hemodynamic and renal effects as well as the effect on plasma cyclic(More)
Die Zahl von Patienten mit multiresistenten Erregern (MRE) in Rehabilitationseinrichtungen nimmt zu. Der dadurch steigende hygienemedizinische Mehraufwand mindert Ressourcen für rehabilitative Kernleistungen. Neben der so entstehenden Fehlversorgung besteht ein weiteres Risiko darin, dass MRE-tragende Patienten nur noch nachrangig in(More)
  • 1